Sun Pharmaceutical Industries Ltd

Sun Pharma.Inds. | 524715

Market Closed

₹1,763.90

+₹0.00 (+0.39%)

As on 18/11/25, 9:02 PM

Market Cap4,21,587.15 CR

Current Price₹1,763.9

High / Low₹1,910 / 1,548

PE Ratio38.1

Book Value₹301

Dividend Yield0.92%

ROCE19.52%

ROE17.83%

Face Value₹2.00

Current Vol.14,30,618

Average Vol.12,76,53,456

ISININE044A01036

PB Ratio5.77

Debt to Equity0.04

Net Profit Margin20.88

Operating Margin31.49

Stock cgart

Stock Performance

₹2,480₹2,490

₹2,500

Previous CloseToday's Open

₹1,800₹3,000

₹2,500

52W Low52W High

₹2,480Today's Open

₹2,490Previous Close

12,00,000Volume

₹1,80052W Low

₹3,00052W High

Ratios

No data available

About Company

Sun Pharmaceutical Industries Limited including its subsidiaries and associates is the fourth largest global specialty generic company that is ranked No
It is the largest Indian pharmaceutical company in the US and among the leading Indian pharmaceutical companies in emerging markets
The company manufactures and markets a large basket of pharmaceutical formulations covering a broad spectrum of chronic and acute therapies
It includes generics, branded generics, complex or difficult to make technology intensive products, over-the-counter (OTC) products, anti-retrovirals (ARVs), Active Pharmaceutical Ingredients (APIs) and intermediates
The product portfolio of over 2000 high quality molecules covers multiple dosage forms, including tablets, capsules, injectables, sprays, inhalers, drug delivery systems, ointments, creams and liquids
The products cater to a vast range of therapeutic segments covering psychiatry, anti-infectives, neurology, cardiology, orthopaedic, diabetology, gastroenterology, ophthalmology, nephrology, urology, dermatology, gynaecology, respiratory, oncology, dental and nutritionals
The company has global presence with 40 manufacturing facilities across the world
Sun Pharmaceutical Industries Limited was incorporated in 1983
The company began operations in Kolkata with just 5 products to treat psychiatry ailments
They set up a compact manufacturing facility for tablets/capsules at Vapi

Research Calls

Explore all active research calls & maximize your profits

To access, login or signup with ArihantPlus

;

Technical Indicators

RSI72.45

SMA 201705.79

SMA 501657.89

SMA 1001656.36

SMA 2001682.88

SMA 101717.81

MACD_12_26_Days23.95

EMA10Day1726.45

EMA20Day1706.58

EMA50Day1677.12

MACD_12_26_9_Days4.88

EMA100Day1671.93

EMA200Day1676.63

Pivot Points

Volume Analysis

Growth Rate

Revenue Growth8.42%

ROE16.16%

EBITDA Margin31.49%

All figures in ₹ Crores

Indicators	2025	2024	2023	2022	2021
Revenue	52,578.44	48,496.85	43,885.68	38,654.49	33,498.14
Interest	231.36	238.47	172.00	127.35	141.43
Expenses	37,492.28	35,509.85	32,238.89	28,410.73	25,030.42
Financing Profit	17,236.73	14,377.32	12,281.31	11,319.23	9,326.89
Financing Margin %	33%	30%	28%	29%	28%
Other Income	2,150.57	1,390.32	634.52	1,075.47	859.17
Depreciation	2,575.39	2,556.64	2,529.43	2,143.74	2,079.95
Profit before tax	13,752.13	11,087.89	9,408.43	4,481.32	2,799.37
Tax %	20%	13%	9%	24%	18%
Net Profit	10,980.10	9,648.44	8,560.84	3,405.82	2,284.68
EPS in Rs	45.60	39.90	35.30	13.60	12.10

Show % Change

ShareHolding

📊

No Information Available

No shareholding data available at this time.

Deal	Date	Type	Quantity	Price	Traded %
GQG PARTNERS EMERGING MARKETS EQUITY CIT	18 Nov ‘25	Purchase	14,46,414	₹1,763.9	101.18%
RELIANCE TRUST INSTITUTIONAL RETIREMENT TRUST SERIES TWELVE	18 Nov ‘25	Sell	14,46,414	₹1,763.9	101.18%
GOLDMAN SACHS BANK EUROPE SE - ODI	09 Oct ‘25	Purchase	1,48,233	₹1,631.6	6.75%
GOLDMAN SACHS (SINGAPORE) PTE - ODI	09 Oct ‘25	Sell	1,48,233	₹1,631.6	6.75%
THE MTBJ LTD.AS TRST FOR GOVERNMENT PENSION INVESTMENT FUND MTBJ400045849	14 Jul ‘25	Purchase	3,09,391	₹1,672	23.62%
THE MTBJ LTD. AS TRST FOR GOVRNMNT PENSION INVSTMNT FUND MTBJ400045828	14 Jul ‘25	Sell	3,09,391	₹1,672	23.62%
MARSHALL WACE INVESTMENT STRATEGIES MARKET NEUTRAL TOPS FUND	25 Jan ‘24	Purchase	1,27,712	₹1,382.1	6.83%
MARSHALL WACE INVESTMENT STRATEGIES EUREKA FUND	25 Jan ‘24	Purchase	26	₹1,382.1	0.00%
MARSHALL WACE INVESTMENT STRATEGIES TOPS FUND	25 Jan ‘24	Purchase	3,160	₹1,382.1	0.17%
SOCIETE GENERALE	25 Jan ‘24	Sell	1,30,898	₹1,382.1	7.00%

News

17 Nov 2025 12:00 am

Astrazeneca Pharma and Sun Pharma form second brand partnership

13 Nov 2025 12:00 am

Sun Pharmaceutical Industries Ltd up for fifth session

Record Date

Corporate Action

Information

Announcement Day

31 Jul 2025

AGM

22 May 2025

07 Jul 2025

Final Dividend (₹5.5)

Board recommended final dividend Final dividend of Rs. 5.50/- (Rupees Five and Paise Fifty only) per equity share of Re. l/- (Rupee One only) each is recommended to the shareholders for their approval at the ensuing Annual General Meeting of the Company. Monday, 07 July 2025 is fixed as the Record Date for the purpose of determining the Members eligible to receive the final dividend, which, if approved at the Annual General Meeting, shall be paid on or before Friday, 08 August 2025

22 May 2025

06 Feb 2025

Interim Dividend (₹10.5)

Board approved interim dividend for FY 2024-25

31 Jan 2025

21 Jan 2025

EGM

10 Dec 2024

05 Aug 2024

AGM

19 Jun 2024

12 Jul 2024

Final Dividend (₹5)

Board of Directors of the Company was held today i.e. May 22, 2024 Final dividend of Rs. 5/- (Rupees Five only) per equity share of Re. l/- (Rupee One only) each is recommended to the shareholders for their approval at the ensuing Annual General Meeting of the Company. Final dividend, once approved by the shareholders, shall be to be paid within the prescribed timeline under the Companies Act, 2013.

22 May 2024

09 Feb 2024

Interim Dividend (₹8.5)

Meeting of the Board of Directors of the Company ('Board') was held today i.e. January 31, 2024 which commenced at 10:20 a.m. and ended at 1:55 p.m., IST. The Board has, inter-alia, approved the following: Declaration of Interim Dividend for the financial year 2023-24 An interim dividend of Rs. 8.5/- (Rupees Eight and fifty paisa only) per equity share of Re. l/- (Rupee one only) each of the Company for the financial year 2023-24 is declared. As intimated on January 15, 2024, the Record Date for entitlement of interim dividend for the financial year 2023-24 is February 09, 2024. The interim dividend shall be paid on or before February 23, 2024.

31 Jan 2024

28 Aug 2023

AGM

07 Jul 2023

28 Jul 2023

Final Dividend (₹4)

With reference to the intimation of Board meeting submitted on May 11, 2023, we wish to inform you that the Meeting of the Board of Directors of the Company was held today i.e. May 26, 2023 which commenced at 10:40 a.m. and ended at 02:35 p.m., wherein the Board has, inter-alia, Recommended Final Dividend for financial year 2022-23 Final dividend of Rs. 4.00/- (Rupees Four only) per equity share of Re. l/- (Rupee One only) each of the Company is recommended subject to approval of the shareholders at the ensuing 31st Annual General Meeting and which shall be paid within the timelines as required under the Companies Act, 2013.

26 May 2023

08 Feb 2023

Interim Dividend (₹7.5)

The Board has, inter-alia, Considered and approved declaration of Interim Dividend for the financial year 2022-23 An interim dividend of Rs. 7.50/- (Rupees seven and paise fifty only) per equity share of Re. l/- (Rupee one only) each of the Company for the financial year 2022-23. Further, as already intimated on January 16, 2023, the Record Date for entitlement of interim dividend for the financial year 2022-23 is February 08, 2023. The interim dividend shall be paid on or before February 20, 2023.

31 Jan 2023

Peers

LTP(₹)	Market Cap(₹ Cr.)	P/E Ratio(Ratio)	P/B Ratio(Ratio)	Cash Earnings(Ratio)	Debt to Equity(Ratio)	Net Profit Ratio(%)
1,760	4,22,211	37	5	30	0	20.88%
6,475	1,71,898	69	11	59	0	23.41%
3,793	1,28,372	59	15	43	1	16.60%
1,515	1,22,349	22	4	19	0	19.21%
1,244	1,03,789	18	3	14	0	17.54%
2,047	93,506	22	5	17	0	14.56%
928	93,404	19	4	15	0	19.86%
2,224	91,800	53	6	35	0	14.39%
1,240	72,630	21	2	14	0	10.98%
5,711	68,288	29	5	25	0	17.09%

Showing 10 of 124 Results

#IndiaInvests

Trusted by 2.5 lac + Indians for their wealth-building needs

Invest in stocks with ease

Open your account in less than 10 mins*

By proceeding, you agree to all T&C *

Top Gainers

Top Losers

Frequently Asked Questions

What is Share Price of Sun Pharmaceutical Industries Ltd?

The current share price of Sun Pharmaceutical Industries Ltd (Sun Pharma.Inds.) is ₹1763.90. This price reflects the latest market valuation and is updated in real-time during trading hours.

What is the P/E Ratio of Sun Pharmaceutical Industries Ltd?

The Price-to-Earnings (P/E) ratio of Sun Pharmaceutical Industries Ltd is 1763.90. This indicates how much investors are willing to pay per rupee of earnings, helping assess if the stock is overvalued or undervalued.

What is the 52-week high and low of Sun Pharmaceutical Industries Ltd?

Sun Pharmaceutical Industries Ltd has a 52-week high of ₹1910.00 and a 52-week low of ₹1548.00. This range shows the stock's price volatility over the past year.

What is the Dividend Yield of Sun Pharmaceutical Industries Ltd?

Sun Pharmaceutical Industries Ltd offers a dividend yield of 0.91%. This represents the annual dividend payment as a percentage of the current stock price, indicating the income return for investors.

What is the EPS of Sun Pharmaceutical Industries Ltd?

The Earnings Per Share (EPS) of Sun Pharmaceutical Industries Ltd is ₹48.13. EPS indicates the company's profitability on a per-share basis and is a key metric for evaluating financial performance.

What is the ROE of Sun Pharmaceutical Industries Ltd?

Sun Pharmaceutical Industries Ltd has a Return on Equity (ROE) of 17.83%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.

Disclaimer:

Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.

Ready to invest smarter?
Download the app today.

GET IT ON

Google Play

4.5

DOWNLOAD ON THE

App Store

4.2

Discover our app's power in seconds.